Recruiting

Observational Study

Sponsor:

CorEvitas

Code:

NCT06562270

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.

Conditions

Alopecia Areata

Study ID

NCT06562270

Start date

Mar 7, 2024

Status verified date

Aug, 2026

Completion date

Dec 31, 2099

Anticipated

Primary completion date

Dec 31, 2099

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Inclusion Criteria:

To be eligible to participate in this registry, an individual must meet all the following criteria:

1. Has ever been diagnosed with severe AA by a dermatologist or a qualified healthcare provider.
2. Is 12-17 years of age at the time of enrollment.
3. Is willing to provide consent/assent for participation in the registry.

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in the registry:

1. Is participating or planning to participate in a blinded clinical trial for any investigational medication.
2. Is unwilling or unable to provide standing height measurements.

Study Design

Enrollment

1500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • AA epidemiology, presentation, natural history, management, and outcomes [ Time Frame: Through Study completion until the subject is 18 years ]

Central Contacts and Locations

Locations

CorEvitas, LLC

Recruiting

Waltham, Massachusetts, United States, 02451

Contacts

Cathy Cheney

508-555-1212corevitasregistrytrials@corevitas.com

508-555-1212corevitasregistrytrials@corevitas.com

More Information

Sponsor

CorEvitas

Last update posted

Aug 17, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by CorEvitas on 2026-08-17.